February 21, 2019 | Dermapharm continues to drive development of new products
Grünwald, February 21, 2019 – Dermapharm Holding SE (“Dermapharm”), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas in Germany, has launched the products Azedil® and Momekort® in Germany just in time for the hay fever season. In addition, the patented medical product bite away® from the 2018 Hyperthermia range has performed well in all sales channels.
February 15, 2019 | KPS publishes figures on the first quarter of 2018/2019 – sales and EBITDA are within the forecast
Sales significantly increased by 16.5 % to 44.4 million euros
EBITDA increased twofold to 6.6 million euros by comparison with the first quarter of 2017/2018
Attainment of important project milestones in existing projects with customers in the Scandinavian market and new opportunities presented as a result of internationaliza-tion
Important for all IR managers | Update capital market law: The paying agent must be mentioned on the IR websites of the issuers
Pursuant to Paragraph 48 (1) No. 2 in conjunction with No. 4 WpHG, listed companies have to publish information on their paying agent. The paying agent is the bank through which the issuer processes, in particular, dividend payments.
New Shareholder Rights Policy for EU Member States
The approval rates for executive board remuneration at the annual general meetings of German index companies have developed negatively over the past three years. Shareholders are increasingly dissatisfied with the salaries of German board members.
IR 2019
On Tuesday, 29 January the seventh edition of the “Conference of the IR Community” was held at the Sofitel Opera Frankfurt.: a full success! More than 180 IR experts were present, exchanged views on current investor relations topics and benefited from 21 excellent presentations. The 38 speakers all held their presentations at a very high […]
January 29, 2019 | KPS publishes Annual Report 2017/2018 – Significant sales growth and robust result
Unterföhring/Munich, 29 January 2019 – KPS AG (WKN: A1A6V4 / ISIN: DE000A1A6V48), Europe’s leading management consultant for business transformation and process optimization, today publishes its Annual Report 2017/2018, and information about the forecast for 2018/2019.
January 24, 2019 | zooplus AG: Sales increase 21% in 2018 to more than EUR 1.3 bn
Corporate news to the archive zooplus AG: Sales increase 21% in 2018 to more than EUR 1.3 bn Sales increase by EUR 231 m to EUR 1,342 m in 2018 (2017: EUR 1,111 m) Double-digit growth achieved in all 30 regional markets Sales of private label products grow disproportionally, rising 35% Sales retention rate increases […]
22 January 2019| Effective immediately, MyTicket a 100% subsidiary of DEAG
DEAG Deutsche Entertainment Aktiengesellschaft (DEAG), Berlin, ISIN: DE000A0Z23G6, Ticker: ERMK, which is listed in the Prime Standard of the Frankfurt Stock Exchange, is acquiring 24.9% of the shares in mytic myticket AG (“MyTicket AG”) from Axel Springer SE and will thus hold 100% of the company in the future.
January 23, 2019 | Dermapharm continues expansion course
Grünwald, January 23, 2019 – Dermapharm Holding SE (“Dermapharm”), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas in Germany with a growing international presence, is continuing its expansion course at the beginning of the year. The acquisition of the Spanish company EUROMED S.A. was completed at the beginning of January 2019.
Listed companies with deficits in forecast quality
cometis AG, one of the leading investor relations agencies, has examined the forecast quality of all DAX, MDAX, SDAX and TecDAX companies for the years 2013 to 2017.